Cargando…
Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative condition where loss of motor neurons within the brain and spinal cord leads to muscle atrophy, weakness, paralysis and ultimately death within 3–5 years from onset of symptoms. The specific molecular mechanisms underlyin...
Autores principales: | Ciervo, Yuri, Ning, Ke, Jun, Xu, Shaw, Pamela J., Mead, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683324/ https://www.ncbi.nlm.nih.gov/pubmed/29132389 http://dx.doi.org/10.1186/s13024-017-0227-3 |
Ejemplares similares
-
Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation
por: Mead, Richard J., et al.
Publicado: (2022) -
Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis
por: Richardson, Peter J., et al.
Publicado: (2023) -
Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis
por: Vidovic, Maximilian, et al.
Publicado: (2023) -
CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions
por: Mehta, Paul, et al.
Publicado: (2017) -
Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions
por: Grollemund, Vincent, et al.
Publicado: (2019)